Dr. Reddy’s forays into India’s biosimilar immuno-oncology market, launches Nivorz
Dr. Reddy’s launches Nivorz, a biosimilar for immuno-oncology, enhancing patient access to affordable cancer treatment in India.
15 Sep 16:03 · The Hindu
Dr. Reddy’s forays into India’s biosimilar immuno-oncology market, launches Nivorz
Dr. Reddy’s launches Nivorz, a biosimilar for immuno-oncology, enhancing patient access to affordable cancer treatment in India.
15 Sep 16:03 · The Hindu
last updated on 15 Sep 18:59